Literature DB >> 35322380

A methodological framework for AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET-CT images: Initial analysis.

Lisa Duff1,2, Andrew F Scarsbrook3,4, Sarah L Mackie5,6, Russell Frood3,4, Marc Bailey7,8, Ann W Morgan7,6, Charalampos Tsoumpas7,9,10.   

Abstract

BACKGROUND: The aim of this study was to explore the feasibility of assisted diagnosis of active (peri-)aortitis using radiomic imaging biomarkers derived from [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) images.
METHODS: The aorta was manually segmented on FDG PET-CT in 50 patients with aortitis and 25 controls. Radiomic features (RF) (n = 107), including SUV (Standardized Uptake Value) metrics, were extracted from the segmented data and harmonized using the ComBat technique. Individual RFs and groups of RFs (i.e., signatures) were used as input in Machine Learning classifiers. The diagnostic utility of these classifiers was evaluated with area under the receiver operating characteristic curve (AUC) and accuracy using the clinical diagnosis as the ground truth.
RESULTS: Several RFs had high accuracy, 84% to 86%, and AUC scores 0.83 to 0.97 when used individually. Radiomic signatures performed similarly, AUC 0.80 to 1.00.
CONCLUSION: A methodological framework for a radiomic-based approach to support diagnosis of aortitis was outlined. Selected RFs, individually or in combination, showed similar performance to the current standard of qualitative assessment in terms of AUC for identifying active aortitis. This framework could support development of a clinical decision-making tool for a more objective and standardized assessment of aortitis.
© 2022. The Author(s).

Entities:  

Keywords:  Diagnosis; FDG PET/CT; Giant cell arteritis; Large-vessel vasculitis; Radiomic feature analysis

Year:  2022        PMID: 35322380     DOI: 10.1007/s12350-022-02927-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  38 in total

1.  Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.

Authors:  Jianhua Wu; Adam Keeley; Christian Mallen; Ann W Morgan; Mar Pujades-Rodriguez
Journal:  CMAJ       Date:  2019-06-24       Impact factor: 8.262

2.  Utility of multimodality imaging in diagnosis and follow-up of aortitis.

Authors:  Vikas Veeranna; Alexander Fisher; Prashant Nagpal; Nina Ghosh; Edward Fisher; Michael Steigner; Mark A Creager; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2015-07-18       Impact factor: 5.952

3.  Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.

Authors:  Jessica C Wilson; Khaled Sarsour; Neil Collinson; Katie Tuckwell; David Musselman; Micki Klearman; Pavel Napalkov; Susan S Jick; John H Stone; Christoph R Meier
Journal:  Semin Arthritis Rheum       Date:  2016-11-28       Impact factor: 5.532

4.  F-18 FDG PET for assessment of disease activity of large vessel vasculitis: A systematic review and meta-analysis.

Authors:  Sang-Woo Lee; Seong-Jang Kim; Youngduk Seo; Shin Young Jeong; Byeong-Cheol Ahn; Jaetae Lee
Journal:  J Nucl Cardiol       Date:  2018-08-17       Impact factor: 5.952

Review 5.  PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.

Authors:  Matthieu Pelletier-Galarneau; Terrence D Ruddy
Journal:  Curr Cardiol Rep       Date:  2019-03-18       Impact factor: 2.931

6.  British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.

Authors:  Sarah L Mackie; Christian Dejaco; Simone Appenzeller; Dario Camellino; Christina Duftner; Solange Gonzalez-Chiappe; Alfred Mahr; Chetan Mukhtyar; Gary Reynolds; Alexandre Wagner S de Souza; Elisabeth Brouwer; Marwan Bukhari; Frank Buttgereit; Dorothy Byrne; Maria C Cid; Marco Cimmino; Haner Direskeneli; Kate Gilbert; Tanaz A Kermani; Asad Khan; Peter Lanyon; Raashid Luqmani; Christian Mallen; Justin C Mason; Eric L Matteson; Peter A Merkel; Susan Mollan; Lorna Neill; Eoin O' Sullivan; Maria Sandovici; Wolfgang A Schmidt; Richard Watts; Madeline Whitlock; Elaine Yacyshyn; Steven Ytterberg; Bhaskar Dasgupta
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

7.  Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.

Authors:  Jianhua Wu; Mar Pujades-Rodriguez; Sarah L Mackie
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

8.  Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.

Authors:  Mar Pujades-Rodriguez; Ann W Morgan; Richard M Cubbon; Jianhua Wu
Journal:  PLoS Med       Date:  2020-12-03       Impact factor: 11.069

Review 9.  FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.

Authors:  Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-11       Impact factor: 9.236

10.  Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.

Authors:  Sara Monti; Ana F Águeda; Raashid Ahmed Luqmani; Frank Buttgereit; Maria Cid; Christian Dejaco; Alfred Mahr; Cristina Ponte; Carlo Salvarani; Wolfgang Schmidt; Bernhard Hellmich
Journal:  RMD Open       Date:  2019-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.